title: Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study.
abstract: BACKGROUND
  The high mortality of hip fracture patients is well documented, but sex- and cause-specific mortality after hip fracture has not been extensively studied. The purpose of the present study was to evaluate mortality and cause of death in patients after hip fracture surgery and to compare their mortality and cause of death to those in the general population.
  
  
  METHODS
  Records of 428 consecutive hip fracture patients were collected on a population-basis and data on the general population comprising all Finns 65 years of age or older were collected on a cohort-basis. Cause of death was classified as follows: malignant neoplasms, dementia, circulatory disease, respiratory disease, digestive system disease, and other.
  
  
  RESULTS
  Mean follow-up was 3.7 years (range 0-9 years). Overall 1-year postoperative mortality was 27.3% and mortality after hip fracture at the end of the follow-up was 79.0%. During the follow-up, age-adjusted mortality after hip fracture surgery was higher in men than in women with hazard ratio (HR) 1.55 and 95% confidence interval (95% CI) 1.21-2.00. Among hip surgery patients, the most common causes of death were circulatory diseases, followed by dementia and Alzheimer's disease. After hip fracture, men were more likely than women to die from respiratory disease, malignant neoplasm, and circulatory disease. During the follow-up, all-cause age- and sex-standardized mortality after hip fracture was 3-fold higher than that of the general population and included every cause-of-death category.
  
  
  CONCLUSIONS
  During the study period, the risk of mortality in hip fracture patients was 3-fold higher than that in the general population and included every major cause of death.
authors: Department of Surgery, City Hospital of Pori, Pori, Finland. jorma.panula@fimnet.fi
authors: Jorma
authors: J
authors: Panula
authors: Harri
authors: H
authors: Pihlajamäki
authors: Ville M
authors: VM
authors: Mattila
authors: Pekka
authors: P
authors: Jaatinen
authors: Tero
authors: T
authors: Vahlberg
authors: Pertti
authors: P
authors: Aarnio
authors: Sirkka-Liisa
authors: SL
authors: Kivelä
references: J Am Geriatr Soc. 2002 Apr;50(4):685-90
references: 11982669
references: J Bone Miner Res. 2003 Dec;18(12):2231-7
references: 14672359
references: Scand J Surg. 2003;92(3):232-4
references: 14582549
references: Arch Intern Med. 1996 Jul 22;156(14):1521-5
references: 8687260
references: Ann Oncol. 2010 Jun;21(6):1323-1360
references: 19948741
references: Osteoporos Int. 2009 Oct;20(10):1633-50
references: 19421703
references: Scand J Prim Health Care. 2003 Sep;21(3):178-81
references: 14531511
references: Calcif Tissue Int. 2006 Feb;78(2):72-7
references: 16467975
references: Osteoporos Int. 2007 Jun;18(6):721-32
references: 17216129
references: Ann Med. 2005;37(4):303-10
references: 16019730
references: Osteoporos Int. 1998;8(1):92-5
references: 9692083
references: Injury. 2007 Mar;38(3):312-7
references: 17141780
references: Tob Control. 1999 Summer;8(2):161-8
references: 10478400
references: Clin Orthop Relat Res. 2006 Oct;451:212-7
references: 16770284
references: J Trauma. 1989 Dec;29(12):1673-8
references: 2593199
references: Cochrane Database Syst Rev. 2002;(4):CD000305
references: 12519540
references: Osteoporos Int. 2007 Dec;18(12):1583-93
references: 17566814
references: Methods Inf Med. 2007;46(5):558-66
references: 17938779
references: Acta Orthop Scand. 2002 Aug;73(4):425-31
references: 12358116
references: Osteoporos Int. 2005 Dec;16(12):1583-90
references: 16217590
references: Clin Orthop Relat Res. 1995 Oct;(319):260-5
references: 7554638
references: Eur J Epidemiol. 2008;23(11):747-55
references: 18830674
references: BMJ. 2005 Dec 10;331(7529):1374
references: 16299013